GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,604.50p
   
  • Change Today:
    -5.50p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.96m
  • Volume: 4,229,876
  • Market Cap: £66,506m
  • RiskGrade: 129

Latest ShareCast News

Zantac litigation fears overdone at GSK, says Shore Capital

By Benjamin Chiou

Date: Tuesday 11 Jun 2024

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

GSK launches appeal to recent Zantac ruling

By Josh White

Date: Tuesday 11 Jun 2024

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

GSK's Arexvy vaccine approved for wider age range

By Benjamin Chiou

Date: Monday 10 Jun 2024

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

GSK shares slump as US judge says experts can te... 03-Jun-2024 ShareCast
London close: Stocks mixed after disappointing r... 24-May-2024 ShareCast
Jury rules in favour of GSK in Zantac trial 24-May-2024 ShareCast
GSK reports promising results from asthma treatm... 21-May-2024 ShareCast
London close: Stocks recoup some earlier losses 17-May-2024 ShareCast
GSK raises £1.25bn from sale of remaining Haleon... 17-May-2024 ShareCast
London close: Stocks mixed as ex-divs drag on FTSE 16-May-2024 ShareCast
GSK to sell remaining 4.2% stake in Haleon 16-May-2024 ShareCast
London close: Stocks fall ahead of US Fed decision 01-May-2024 ShareCast
GSK lifts annual guidance on strong virus treatm... 01-May-2024 ShareCast
GSK's endometrial cancer drug receives FDA appro... 24-Apr-2024 ShareCast
GSK posts promising results from gonorrhoea trea... 17-Apr-2024 ShareCast
GSK meningococcal vaccine accepted by US FDA for... 16-Apr-2024 ShareCast
GSK unveils promising results from endometrial c... 18-Mar-2024 ShareCast
GSK reports more encouraging trial results for B... 07-Mar-2024 ShareCast
GSK's ViiV upbeat on ultra-long-acting HIV treat... 05-Mar-2024 ShareCast
GSK reaches settlement in another Zantac case 29-Feb-2024 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,604.50p
Change Today -5.50p
% Change -0.34 %
52 Week High 1,812.50
52 Week Low 1,316.00
Volume 4,229,876
Shares Issued 4,144.96m
Market Cap £66,506m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.34% below the market average54.34% below the market average54.34% below the market average54.34% below the market average54.34% below the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average
Price Trend
31.01% above the market average31.01% above the market average31.01% above the market average31.01% above the market average31.01% above the market average
47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average
Income
21.31% above the market average21.31% above the market average21.31% above the market average21.31% above the market average21.31% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
20.43% below the market average20.43% below the market average20.43% below the market average20.43% below the market average20.43% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

What The Brokers Say

Strong Buy 8
Buy 4
Neutral 10
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 14-Jun-2024

Time Volume / Share Price
16:35 35,372 @ 1,604.50p
16:35 2,548 @ 1,604.50p
16:35 2,217,428 @ 1,604.50p
16:35 2,192 @ 1,604.50p
16:35 1,750 @ 1,604.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page